Cumberland Settles 2 Patent Suits Over Generic Acetadote

Law360, New York (November 14, 2012, 6:13 PM EST) -- Cumberland Pharmaceuticals Inc. has settled two patent infringement lawsuits against drugmakers Perrigo Co. and Paddock Laboratories LLC, which attempted to market a generic version of its acetaminophen-overdose treatment Acetadote.

Cumberland announced the settlement Monday in a Form 8-K filing with the U.S. Securities and Exchange Commission, in which the company stated that Perrigo and Paddock agreed not to challenge its Acetadote patent. Perrigo acquired Minneapolis-based Paddock in July. The terms of the settlement call for Perrigo to launch a generic version of Acetadote upon the patent's...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.